Travelers seek structured itineraries with options, expert guidance, balance between highlights and exploration time.

Invesco Ltd‘s “Small Cap Value Fund” released its Q4 2025 investor letter. A copy of the letter can be downloaded here. The ...

Globus Medical (NYSE:GMED) reported record Q4 and full year results, supported by its U.S. Spine and Trauma businesses and ...

Globus Medical cites successful integration of NuVasive and Nervo and strong domestic spine sales growth as drivers in strong ...

Globus Medical Q4 sales hit $826.4M, up 25.7%, driven by spine growth and successful NuVasive, Nevro integrations; analysts ...

AUDUBON, Pa., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it has completed its previously announced merger with ...

Medical device company Globus Medical (NYSE:GMED) will be reporting results this Tuesday after market close. Here’s what to ...

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter ...

Medical device company Globus Medical (NYSE:GMED) reported in Q4 CY2025, with sales up 25.7% year on year to $826.4 million.

Globus Medical saw nearly $3 billion in full-year net sales, according to financial results posted Feb. 24. Five things to ...

CEO Dan Scavilla noted that Q1 revenue was $598 million, with a slight decline of 0.8% year-over-year on a constant currency basis. Issues impacting sales included temporary supply chain disruptions, ...